医学
妊娠期糖尿病
产科
怀孕
糖尿病
相对风险
荟萃分析
产后
妇科
妊娠期
内科学
内分泌学
置信区间
遗传学
生物
作者
Adarsh Pal,Dimple Rawat,Sankeerth Sadananda,Alpesh Goyal,Partha Haldar,Deepali Garg,Yashdeep Gupta,Nikhil Tandon
摘要
Abstract Background and Aim Overt diabetes in pregnancy (ODiP) is a condition identified by the International Association of Diabetes and Pregnancy Study Groups (IADPSG) in 2010. Despite the clinical significance, our knowledge regarding its impact during pregnancy and the postpartum period is limited due to small sample sizes in previous studies. This systematic review and meta‐analysis (SRM) aimed to consolidate evidence on outcomes in the pregnancy and postpartum period among women with ODiP in comparison to women with gestational diabetes mellitus (GDM), pre‐existing diabetes (PED) and normoglycaemia. Material and Methods A comprehensive search was conducted across PubMed, Embase and Scopus for relevant studies published from January 1, 2010, to May 31, 2024. Eleven studies, including data from 16 135 pregnancies, were analysed. Results Women with ODiP had a significantly higher risk of gestational hypertension (RR 1.93; 95% CI 1.45, 2.58), pre‐eclampsia (RR 1.65; 95% CI 1.26, 2.16) and caesarean delivery (RR 1.14; 95% CI 1.01, 1.29) compared with GDM. Adverse neonatal outcomes such as large for gestational age (RR 1.45; 95% CI 1.13, 1.85), macrosomia (RR 1.66; 95% CI 1.05, 2.64), neonatal hypoglycaemia (RR 1.52; 95% CI 1.06, 2.19) and stillbirth (RR 4.30; 95% CI 1.69, 10.98) were also significantly higher than GDM. The risk of postpartum diabetes was 6 times higher than in women with GDM and 25 times higher than in women with normoglycaemia. Variations in diagnostic criteria and postpartum follow‐up duration contributed to heterogeneity. Conclusion This SRM demonstrates that ODiP is associated with significantly worse pregnancy and postpartum outcomes compared with GDM and normoglycaemia in pregnancy. These findings underscore the need for targeted clinical strategies to manage ODiP and mitigate adverse maternal and neonatal outcomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI